Brief Research Report
Published on 30 Sep 2025
Nefazodone shortage in the United States: analysis of drug switching and utilization
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1613275
- 1,820 views
Type at least 3 characters
588 articles
Original Research
Published on 29 Sep 2025
Arrhythmic events pertinent with antidepressants: a Bayesian disproportional analysis mining the FDA Adverse Event Reporting System database
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1637471
- 766 views
Original Research
Published on 26 Sep 2025
Recreational MDMA use in Norway: results from an internet convenience sample
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1619676
- 1,970 views
Case Report
Published on 23 Sep 2025
A case report of seizure worsening after perampanel add-on to oxcarbazepine: possible role of metabolic interaction and pharmacogenetics
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1621598
- 1,229 views
Systematic Review
Published on 22 Sep 2025
Reporting of harms in systematic reviews focused on naltrexone: a cross-sectional study
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1597019
- 956 views
Perspective
Published on 22 Sep 2025
The collective lie in ketamine therapy: a call to realign clinical practice with neurobiology
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1610335
- 1,664 views
Original Research
Published on 17 Sep 2025
Changes in self-reported alcohol consumption at high and low consumption in the wake of the COVID-19 pandemic: a test of the polarization hypothesis
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1516090
- 1,170 views
Original Research
Published on 12 Sep 2025
Medication adherence in obsessive-compulsive disorders and evaluation of effective adherence support strategies
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1642622
- 1,618 views
Correction
Published on 11 Sep 2025
Correction: Therapeutic and legal aspects of psilocybin in cancer-related depression
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1698185
- 1,025 views
Hypothesis and Theory
Published on 09 Sep 2025
A framework for safe estradiol modulation in male bipolar disorder: theoretical justification for SERM-enabled adjunctive therapy
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1644175
- 1,574 views
Clinical Trial
Published on 02 Sep 2025
Mindfulness, music, visual occlusion in ketamine therapy for depression: do they change outcomes? A qualitative and quantitative analysis of a randomized controlled trial
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1642025
- 1,731 views
Perspective
Published on 01 Sep 2025
Psychedelic therapy: bridging neuroplasticity, phenomenology, and clinical outcomes
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1637162
- 1,615 views
Review
Published on 01 Sep 2025
Optimizing long-acting injectable antipsychotic safety and care continuity through documentation best practices
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1659290
- 1,401 views
Case Report
Published on 28 Aug 2025
Case Report: Clinical pharmacist prescriber in depression treatment in primary care settings: clinical case focused on prescribing practice
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1677152
- 1,245 views
Original Research
Published on 28 Aug 2025
Pharmacist-assisted implementation of guideline recommendations for QTc monitoring during psychopharmacotherapy - a prospective, randomized feasibility study
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1606497
- 985 views
Opinion
Published on 26 Aug 2025
Psychedelic minimalism: the case against music in psychedelic therapy settings
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2025.1652568
- 1,748 views